---
title: Serum levels of B-cell activating factor are associated with a reduced risk
  of chronic lymphocytic leukemia
date: '2024-08-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39112445/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240808182000&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: Immune dysregulation is thought to contribute to chronic lymphocytic
  leukemia (CLL) risk, but biological mechanisms are unclear. We discovered that increased
  serum levels of B-cell activating factor (BAFF), an important regulator of B-cell
  maturation, were associated with a decreased risk of CLL, even >10 years after blood
  draw. Our findings suggest that BAFF could be a useful biomarker to assess risk
  among individuals at high risk, such as those with monoclonal b-cell ...
disable_comments: true
---
Immune dysregulation is thought to contribute to chronic lymphocytic leukemia (CLL) risk, but biological mechanisms are unclear. We discovered that increased serum levels of B-cell activating factor (BAFF), an important regulator of B-cell maturation, were associated with a decreased risk of CLL, even >10 years after blood draw. Our findings suggest that BAFF could be a useful biomarker to assess risk among individuals at high risk, such as those with monoclonal b-cell ...